These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 12880839

  • 1. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment.
    Huang C, Wahlund LO, Almkvist O, Elehu D, Svensson L, Jonsson T, Winblad B, Julin P.
    Neuroimage; 2003 Jul; 19(3):1137-44. PubMed ID: 12880839
    [Abstract] [Full Text] [Related]

  • 2. Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT.
    Huang C, Eidelberg D, Habeck C, Moeller J, Svensson L, Tarabula T, Julin P.
    Neurobiol Aging; 2007 Jul; 28(7):1062-9. PubMed ID: 16824650
    [Abstract] [Full Text] [Related]

  • 3. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment.
    Huang C, Wahlund LO, Svensson L, Winblad B, Julin P.
    BMC Neurol; 2002 Sep 12; 2():9. PubMed ID: 12227833
    [Abstract] [Full Text] [Related]

  • 4. Regional Cerebral Blood Flow in [123]I-IMP Single-photon Emission Computed Tomography and the Wechsler Memory Scale-revised in Nondemented Elderly Subjects with Subjective Cognitive Impairment.
    Niwa F, Kondo M, Sakurada K, Nakagawa M, Imanishi J, Mizuno T.
    Intern Med; 2016 Sep 12; 55(24):3571-3578. PubMed ID: 27980255
    [Abstract] [Full Text] [Related]

  • 5. Working memory load-related electroencephalographic parameters can differentiate progressive from stable mild cognitive impairment.
    Missonnier P, Deiber MP, Gold G, Herrmann FR, Millet P, Michon A, Fazio-Costa L, Ibañez V, Giannakopoulos P.
    Neuroscience; 2007 Dec 05; 150(2):346-56. PubMed ID: 17996378
    [Abstract] [Full Text] [Related]

  • 6. Alteration in temporal-cerebellar effective connectivity can effectively distinguish stable and progressive mild cognitive impairment.
    Xue C, Zheng D, Ruan Y, Guo W, Hu J, Alzheimer’s Disease Neuroimaging Initiative.
    Front Aging Neurosci; 2024 Dec 05; 16():1442721. PubMed ID: 39267723
    [Abstract] [Full Text] [Related]

  • 7. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study.
    Ishiwata A, Sakayori O, Minoshima S, Mizumura S, Kitamura S, Katayama Y.
    Acta Neurol Scand; 2006 Aug 05; 114(2):91-6. PubMed ID: 16867030
    [Abstract] [Full Text] [Related]

  • 8. Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression.
    Wei HC, Li B, Ng KP, Fu QX, Dong SJ, Ba MW, Kong M.
    Chin Med J (Engl); 2021 Jul 20; 134(14):1709-1719. PubMed ID: 34397597
    [Abstract] [Full Text] [Related]

  • 9. HMPAO-SPECT Can Discriminate between Patients with Subjective Cognitive Complaints with and without Cognitive Deficits and those with Mild Cognitive Impairment.
    Rossini F, Zauner H, Bergmann J, Kronbichler M, Spindler I, Golaszewski S, Trinka E, Staffen W.
    Curr Alzheimer Res; 2019 Jul 20; 16(9):843-851. PubMed ID: 31453786
    [Abstract] [Full Text] [Related]

  • 10. Early event-related potential changes during working memory activation predict rapid decline in mild cognitive impairment.
    Missonnier P, Gold G, Fazio-Costa L, Michel JP, Mulligan R, Michon A, Ibáñez V, Giannakopoulos P.
    J Gerontol A Biol Sci Med Sci; 2005 May 20; 60(5):660-6. PubMed ID: 15972621
    [Abstract] [Full Text] [Related]

  • 11. Asymmetric cerebral blood flow in patients with mild cognitive impairment: possible relationship to further cognitive deterioration.
    Edman A, Edenbrandt L, Fredén-Lindqvist J, Nilsson M, Wallin A.
    Dement Geriatr Cogn Dis Extra; 2011 Jan 20; 1(1):228-36. PubMed ID: 22163247
    [Abstract] [Full Text] [Related]

  • 12. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.
    Neurobiol Aging; 2011 Jan 20; 32(1):15-23. PubMed ID: 19250707
    [Abstract] [Full Text] [Related]

  • 13. Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing.
    Vannini P, Almkvist O, Dierks T, Lehmann C, Wahlund LO.
    Psychiatry Res; 2007 Oct 15; 156(1):43-57. PubMed ID: 17719211
    [Abstract] [Full Text] [Related]

  • 14. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, Moriguchi Y, Matsuda H, Nemoto K, Imabayashi E, Yamada M, Iwamoto T, Arima K, Asada T.
    Neuroimage; 2005 Dec 15; 28(4):1014-21. PubMed ID: 16129627
    [Abstract] [Full Text] [Related]

  • 15. NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease.
    Garcia Condado J, Cortes JM, Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement (Amst); 2023 Dec 15; 15(4):e12493. PubMed ID: 37908437
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H, Therriault J, Kang MS, Ng KP, Pascoal TA, Rosa-Neto P, Gauthier S, Alzheimer’s Disease Neuroimaging Initiative.
    Alzheimers Res Ther; 2018 Aug 16; 10(1):80. PubMed ID: 30115118
    [Abstract] [Full Text] [Related]

  • 17. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
    Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, Terzi A, Vignolo LA, Di Luca M, Giubbini R, Padovani A, Perani D.
    Neurobiol Aging; 2006 Jan 16; 27(1):24-31. PubMed ID: 16298237
    [Abstract] [Full Text] [Related]

  • 18. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
    Encinas M, De Juan R, Marcos A, Gil P, Barabash A, Fernández C, De Ugarte C, Cabranes JA.
    Eur J Nucl Med Mol Imaging; 2003 Nov 16; 30(11):1473-80. PubMed ID: 14579086
    [Abstract] [Full Text] [Related]

  • 19. Individual prediction of cognitive decline in mild cognitive impairment using support vector machine-based analysis of diffusion tensor imaging data.
    Haller S, Nguyen D, Rodriguez C, Emch J, Gold G, Bartsch A, Lovblad KO, Giannakopoulos P.
    J Alzheimers Dis; 2010 Nov 16; 22(1):315-27. PubMed ID: 20847435
    [Abstract] [Full Text] [Related]

  • 20. Disrupted Brain Network in Progressive Mild Cognitive Impairment Measured by Eigenvector Centrality Mapping is Linked to Cognition and Cerebrospinal Fluid Biomarkers.
    Qiu T, Luo X, Shen Z, Huang P, Xu X, Zhou J, Zhang M, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2016 Oct 18; 54(4):1483-1493. PubMed ID: 27589525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.